F.M. Djuraev

8 works

Oncology Tashkent Medical Park, Tashkent, Uzbekistan

28P One-week ultra-hypofractionated partial breast RT in early breast cancer: 3DCRT vs IMRT
N.O. Zaynutdinov, A.S. Abdujapparov, F.M. Djuraev +1
ArticleMedical Imaging Techniques and ApplicationsAnnals of Oncology20230 citations
ABI
10P Neoadjuvant chemotherapy with bevacizumab for IIb stage cervical cancer: Is it time to rethink standard of care?
F.M. Djuraev, A.S. Abdujapparov
ArticleEndometrial and Cervical Cancer TreatmentsESMO Open20230 citations
ABI
35P Beyond microsatellite testing: Tumor mutational burden, should it be routine in patients with GI cancers?
F.M. Djuraev, A.S. Abdujapparov
ArticleGenetic factors in colorectal cancerESMO Open20240 citations
ABI
30P Cemiplimab in treatment of metastatic and recurrent cervical cancer
F.M. Djuraev, A.S. Abdujapparov
ArticleCancer Immunotherapy and BiomarkersESMO Open20240 citations
ABI
19P Adjuvant chemotherapy in colon cancer: 6 months better than 3?
Z. Alisher, F.M. Djuraev, A.S. Abdujapparov
ArticleColorectal Cancer Surgical TreatmentsAnnals of Oncology20240 citations
ABI
265P Is it time to change standard care for dMMR locally advanced rectal cancer?
A.S. Abdujapparov, F.M. Djuraev
ArticleColorectal Cancer Surgical TreatmentsAnnals of Oncology20240 citations
ABI
IUC23223-77 Triplet therapy in metastatic hormone-sensitive prostate cancer in Asian patients
Alexey R. Zakirov, F.M. Djuraev, O Raxmonov +1
ArticleProstate Cancer Treatment and ResearchThe Oncologist20250 citations
ABI
63P Combination of pembrolizumab lenvatinib in treatment of advanced hepatocellular carcinoma
Z. Alisher, F.M. Djuraev
ArticleHepatocellular Carcinoma Treatment and PrognosisESMO Open20260 citations
ABI